Linked Life Data

18040821

Source:http://linkedlifedata.com/resource/pubmed/id/18040821

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-11-27
pubmed:abstractText
The goal of this component of the meeting was to discuss novel therapeutics that attenuate inflammatory pathways, enhance drug delivery into the brain and/or bypass the blood-brain barrier (BBB). Presentations included discussions of (i) antiretroviral drugs packaged into nanoparticles by Howard Gendelman, (ii) how to engage the nasal epithelium and its closely associated neural fibers as a route for drug entry to the brain, by William H. Frey and Lynn Pulliam, and (iii) antioxidant gene delivery to neurons using vector systems that can protect neurons against HIV-associated toxicity, by David Strayer. The session was capped by active discourse among leaders in the field of adjunctive therapies in a broad range of scientific disciplines.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1557-1904
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
14-9
pubmed:dateRevised
2008-3-17
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Translational research models and novel adjunctive therapies for neuroAIDS.
pubmed:affiliation
Department of Molecular and Comparative Pathobiology, Johns Hopkins Medicine, Broadway Research Building, Suite 839,733 North Broadway, Baltimore, Maryland 21205, USA. mczink@jhmi.edu
pubmed:publicationType
Journal Article, Review